Literature DB >> 17241691

A prospective clinical trial to evaluate the microbial barrier of a needleless connector.

A L Casey1, S Burnell, H Whinn, T Worthington, M H Faroqui, T S J Elliott.   

Abstract

Needleless connectors are being increasingly used for direct access to intravascular catheters. However, the potential for microbial contamination of these devices and subsequent infection risk is still widely debated. In this study the microbial contamination rate associated with three-way stopcock luers with standard caps attached was compared to those with Y-type extension set luers with Clearlink needleless connectors attached. Fifty patients undergoing cardiothoracic surgery who required a central venous catheter (CVC) as part of their peri- and postoperative management were studied for microbial contamination of CVC luers following 72 hrs in situ. Each patient's CVC was randomly designated to have either the three-way stopcocks with caps (control patients) or Clearlink Y-type extension sets (test patients). Prior to, and following each manipulation of the three-way stopcock luers or Clearlink devices, a 70% (v/v) isopropyl alcohol swab was used for disinfection of the connections. The microbial contamination of 393 luers, 200 with standard caps and 193 with Clearlink attached, was determined. The internal surfaces of 20 of 200 (10%) three-way stopcock luers with standard caps were contaminated with micro-organisms whereas only one of 193 (0.5%) luers with Clearlink attached was contaminated (P<0.0001). These results demonstrate that the use of the Clearlink device with a dedicated disinfection regimen reduces the internal microbial contamination rate of CVC luers compared with standard caps. The use of such needle-free devices may therefore reduce the intraluminal risk of catheter-related bloodstream infection and thereby supplement current preventive guidelines.

Entities:  

Mesh:

Year:  2007        PMID: 17241691     DOI: 10.1016/j.jhin.2006.09.029

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  11 in total

1.  Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

2.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

3.  Needleless closed system does not reduce central venous catheter-related bloodstream infection: a retrospective study.

Authors:  Mitsuru Ishizuka; Hitoshi Nagata; Kazutoshi Takagi; Keiichi Kubota
Journal:  Int Surg       Date:  2013 Jan-Mar

Review 4.  Skin antisepsis for reducing central venous catheter-related infections.

Authors:  Nai Ming Lai; Nai An Lai; Elizabeth O'Riordan; Nathorn Chaiyakunapruk; Jacqueline E Taylor; Kenneth Tan
Journal:  Cochrane Database Syst Rev       Date:  2016-07-13

5.  New materials and devices for preventing catheter-related infections.

Authors:  Jean-François Timsit; Yohann Dubois; Clémence Minet; Agnès Bonadona; Maxime Lugosi; Claire Ara-Somohano; Rebecca Hamidfar-Roy; Carole Schwebel
Journal:  Ann Intensive Care       Date:  2011-08-18       Impact factor: 6.925

Review 6.  Disinfection of Needleless Connector Hubs: Clinical Evidence Systematic Review.

Authors:  Nancy L Moureau; Julie Flynn
Journal:  Nurs Res Pract       Date:  2015-05-14

7.  Closed catheter access system implementation in reducing the bloodstream infection rate in low birth weight preterm infants.

Authors:  Lily Rundjan; Rinawati Rohsiswatmo; Tiara Nien Paramita; Chrissela Anindita Oeswadi
Journal:  Front Pediatr       Date:  2015-03-16       Impact factor: 3.418

Review 8.  Randomized controlled trials in central vascular access devices: A scoping review.

Authors:  Mari Takashima; Gillian Ray-Barruel; Amanda Ullman; Samantha Keogh; Claire M Rickard
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

9.  Risk of infection due to medical interventions via central venous catheters or implantable venous access port systems at the middle port of a three-way cock: luer lock cap vs. luer access split septum system (Q-Syte).

Authors:  Fabian Pohl; Werner Hartmann; Thomas Holzmann; Sandra Gensicke; Oliver Kölbl; Matthias G Hautmann
Journal:  BMC Infect Dis       Date:  2014-01-25       Impact factor: 3.090

Review 10.  Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective.

Authors:  Li Zhang; Samantha Keogh; Claire M Rickard
Journal:  Int J Nanomedicine       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.